Greater Cannabis Company (GCAN) Total Non-Current Liabilities (2016 - 2021)

Greater Cannabis Company's (GCAN) quarterly Total Non-Current Liabilities came in at $460651.0 in Q1 2021, down 53.71% year-on-year from $995119.0 in Q1 2020, and up 4.11% quarter-over-quarter from $442467.0 in Q4 2020.

Greater Cannabis Company (GCAN) Total Non-Current Liabilities (2016 - 2021) Analysis & Trends

Greater Cannabis Company's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $460651.0 for Q1 2021.

  • On a quarterly basis, Total Non-Current Liabilities fell 53.71% year-over-year to $460651.0 in Q1 2021; TTM through Mar 2021 was $460651.0, a 53.71% decrease from a year earlier, with the FY2020 full-year figure at $442467.0, down 72.03% from the prior year.
  • Total Non-Current Liabilities grew to $460651.0 in Q1 2021 per GCAN's latest filing, from $442467.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.6 million in Q4 2019 and bottomed at -$205403.0 in Q4 2017.
  • The 5-year median for Total Non-Current Liabilities is $459956.0 (2019), against an average of $517437.2.
  • Across the five-year window, Total Non-Current Liabilities sank 2437.31% in 2017 and soared 394.54% in 2018, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at -$205403.0 in 2017, then jumped by 394.54% to $604999.0 in 2018, then jumped by 161.46% to $1.6 million in 2019, then slumped by 72.03% to $442467.0 in 2020, then gained by 4.11% to $460651.0 in 2021.
  • Per Business Quant, the three latest GCAN Total Non-Current Liabilities figures stand at $460651.0 (Q1 2021), $442467.0 (Q4 2020), and $599261.0 (Q3 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Greater Cannabis Company 292,929.85 292,929.85 - -

Historic Data

Download Data
DateValue
Mar 31, 2021 460,651.00
Dec 31, 2020 442,467.00
Sep 30, 2020 599,261.00
Jun 30, 2020 774,453.00
Mar 31, 2020 995,119.00
Dec 31, 2019 1.58 Mn
Sep 30, 2019 508,947.00
Jun 30, 2019 459,956.00
Mar 31, 2019 409,882.00
Dec 31, 2018 604,999.00
Sep 30, 2018 401,874.00
Jun 30, 2018 274,624.00
Mar 31, 2018 217,776.00
Dec 31, 2017 -205,403.00
Sep 30, 2017 235,097.00
Dec 31, 2016 8,788.00